Previous Close | 2,828.30 |
Open | 2,836.00 |
Bid | 2,828.30 x 0 |
Ask | 2,833.20 x 0 |
Day's Range | 2,795.05 - 2,852.25 |
52 Week Range | 2,137.25 - 3,147.00 |
Volume | |
Avg. Volume | 49,727 |
Market Cap | 87.347B |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 23.87 |
EPS (TTM) | 118.51 |
Earnings Date | Jan 16, 2025 - Jan 20, 2025 |
Forward Dividend & Yield | 19.00 (0.67%) |
Ex-Dividend Date | Sep 18, 2024 |
1y Target Est | 670.00 |
The partners aim to promote the implementation of FHIR standards and improve patient outcomes by improving data sharing.
As global markets continue to recover from the early August sell-off, hopes for a "soft landing" in the U.S. economy have buoyed investor sentiment. The S&P 600, which tracks small-cap stocks, has also seen gains amid this positive outlook. In such an environment, identifying undervalued small-cap stocks with significant insider action can offer promising opportunities for investors looking to capitalize on market momentum and potential growth.